-
May 26, 2020Elpiscience to Present at the Jefferies 2020 Healthcare Conference
Shanghai, China, May 26th, 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies, today announced ...
-
January 06, 2020Elpiscience Appoints Dr. Steve Chin as Chief Medical Officer
Shanghai, January 6, 2020. Elpiscience Biopharma, Ltd., a clinical-stage biopharmaceutical company announces the appointment of Steve Chin, M.D. as Chief Medical Officer. Dr. Chin brings to th...
-
December 28, 2019Elpiscience Completes Series B Financing of USD $100 Million
December 28, 2019, Shanghai, China, Elpiscience Biopharma announces the completion of Series B financing of 100 million USD. The round was led by Hyfinity Investments, with participation from Tencent,...
-
September 19, 2019Elpiscience to Present ES002/ES004 Data at SITC 2019
Shanghai September 19th 2019, Elpiscience Biopharma, Ltd., a clinical stage immuno-oncology company, announced that it will present data of anti-CD39 and anti-SIRPα antibodies, ES002 a...
-
September 10, 2019Elpiscience Received Second Prize in Merck’s Advance Biotech Grant Program
Shanghai Sep 10th 2019, Elpiscience Biopharma, Ltd., announced that it received the Second Prize, which is valued at 1 million RMB, in the Advance Biotech Grant program sponsored by Merck. T...
-
August 27, 2019Elpiscience Announces Advancement of Two Discovery Molecules into CMC
Shanghai Aug 27th 2019, Elpiscience Biopharma, Ltd., a clinical stage immuno-oncology company, announces that two key molecules in innate immunity have entered into CMC development stage. ...